119 related articles for article (PubMed ID: 9619053)
1. [Cytogenetic analysis of hypophyseal adenoma. Study of 9 cases and review of the literature].
Buonamici L; Roncaroli F; Frank G; Dal Cin P; Van den Berghe H; Calbucci F; Eusebi V
Pathologica; 1998 Apr; 90(2):116-9. PubMed ID: 9619053
[TBL] [Abstract][Full Text] [Related]
2. Simple numerical chromosome aberrations in two pituitary adenomas.
Dietrich CU; Pandis N; Bjerre P; Schrøder HD; Heim S
Cancer Genet Cytogenet; 1993 Sep; 69(2):118-21. PubMed ID: 8402547
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
4. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
[TBL] [Abstract][Full Text] [Related]
5. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
[TBL] [Abstract][Full Text] [Related]
6. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
Jones TH; Figueroa CD; Smith CM; Bhoola KD
Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
[TBL] [Abstract][Full Text] [Related]
7. Simple numerical chromosome aberrations characterize pituitary adenomas.
Larsen JB; Schrøder HD; Sørensen AG; Bjerre P; Heim S
Cancer Genet Cytogenet; 1999 Oct; 114(2):144-9. PubMed ID: 10549272
[TBL] [Abstract][Full Text] [Related]
8. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
[TBL] [Abstract][Full Text] [Related]
9. [A rare case of polyhormonal hypophyseal adenoma].
Aruzmetova DS; Makhmudov EA
Probl Endokrinol (Mosk); 1989; 35(5):54-5. PubMed ID: 2555816
[No Abstract] [Full Text] [Related]
10. Cytogenetic study of pituitary adenomas.
Bettio D; Rizzi N; Giardino D; Persani L; Pecori-Giraldi F; Losa M; Larizza L
Cancer Genet Cytogenet; 1997 Oct; 98(2):131-6. PubMed ID: 9332478
[TBL] [Abstract][Full Text] [Related]
11. Examination of the relationship between chromosome abnormality in pituitary adenomas and tumor invasiveness by normal karyotype analysis and interphase fluorescence staining.
Gao H; Wang Q; Wu S; Hui G
Med Oncol; 2012 Dec; 29(5):3462-6. PubMed ID: 22772969
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor.
Scheick S; Amdur RJ; Kirwan JM; Morris CG; Mendenhall WM; Roper S; Friedman W
Am J Clin Oncol; 2016 Feb; 39(1):49-54. PubMed ID: 25007040
[TBL] [Abstract][Full Text] [Related]
13. [Pituitary adenoma calcification].
Kurisaka M; Mori K; Tindall GT; Takei Y
No To Shinkei; 1986 Dec; 38(12):1187-95. PubMed ID: 3028453
[TBL] [Abstract][Full Text] [Related]
14. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
Ma W; Ikeda H; Yoshimoto T
Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
[TBL] [Abstract][Full Text] [Related]
16. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].
Asano K; Kubo O; Tajika Y; Huang MC; Takakura K
No To Shinkei; 1996 Jun; 48(6):543-9. PubMed ID: 8703557
[TBL] [Abstract][Full Text] [Related]
18. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
[TBL] [Abstract][Full Text] [Related]
19. Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies.
Raverot G; Jouanneau E; Trouillas J
Eur J Endocrinol; 2014 Apr; 170(4):R121-32. PubMed ID: 24431196
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal abnormalities in pituitary adenomas.
Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Rey JA
Cancer Genet Cytogenet; 2001 Jan; 124(1):76-9. PubMed ID: 11165326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
